SVP, Business Development, Licensing, and M&A (ex-China)
Clare Fisher joined BeiGene in 2021 as Senior Vice President, Business Development and Mergers & Acquisitions (ex-China), bringing more than two decades of healthcare experience in leadership roles including corporate and business development, M&A, and strategy.
She joined BeiGene from Kaleido, where she served as Chief Business Officer. She previously had been with Shire plc (now Takeda), where she most recently was Group Vice President, Global Head of Transactions and Business Development, and Interim Head of Corporate Development. Previously, she held senior roles in business development at Cubist Pharmaceuticals, Blueprint Medicines, and Genzyme Corporation.
Ms. Fisher holds a B.S. in biochemistry from the University of Bath, as well as an MBA from Henley Management College in the U.K.